Volunteers in challenging days
Proud of the scientific community’s response in these difficult times! tweeted Ignasi, PhD at the Nanobioengineering group a few days ago. As many other IBEC researchers and staff, Ignasi knows … Read more
Search Results for:
Online IBEC Seminar: Benedetta Bolognesi
Deep mutagenesis to understand Protein Phase Transitions Benedetta Bolognesi , IBEC Specific insoluble protein aggregates are the hallmarks of many neurodegenerative diseases. Whether the protein aggregates themselves or other forms of … Read more
Online IBEC Seminar: Giuseppe Battaglia
Bionics at the molecular level: copying Nature to control Nature Giuseppe Battaglia , IBEC A very established approach in medicine involves the replacement of organs or other malfunctioning body parts … Read more
Online IBEC Seminar: Gabriel Gomila
Multiscale approach to bioelectricity Gabriel Gomila , IBEC Understanding how electricity is generated and propagated in living systems is key to understand many physiological processes and to develop medical instruments … Read more
Núria Montserrat in a feature article at the ERC’s covid-19 section: Stopping coronavirus at the gate
ERC grantee Nuria Montserrat and her team create tiny kidneys which are proving to be key in the search for coronavirus drugs. The researcher is working with other international researchers and found that a trial drug could block early stages of COVID19. The ERC has created a section which is updated with the latest news about the ERC-funded research in coronavirus.
Research4Talent
On Wednesday 20th May we’ll open our doors virtually to UNDERGRADUATE & MASTER’s students interested in a research career The day is a chance for you to talk to our … Read more
The research with organoids against COVID19 reaches the international press
One of the most prestigious German newspapers, the Süddeutsche Zeitung echoes the work of Núria Montserrat and her international partners who are investigating with organoids a drug that blocks the entrance door of Covid19.
PeriCord, a bioimplant for infarcted hearts
The journal “EBioMedicine” of “The Lancet” has just published the procedure that allowed the creation, last year, of the “PeriCord”, the first human cardiac bioimplant, in which development the Institute for Bioengineering of Catalonia (IBEC) played a key role.
The journal “EBioMedicine” of “The Lancet” has just published the procedure that allowed the creation, last year, of the “PeriCord”, the first human cardiac bioimplant, in which development the Institute for Bioengineering of Catalonia (IBEC) played a key role. In May 2019, a collaboration between the ‘Germans Trias i Pujol’ Hospital, the Blood and Tissue Bank (BST) and IBEC took a step forward for heart patients combining medicine, science and engineering.
Bioengineering contributes to new advances against childhood cancer
IBEC contributes to elucidate how the rigidity of the tumor extracellular matrix affects the aggressiveness of neuroblastoma, a cancerous tumor that affects mainly children. This opens the door to generate more accurate models to predict tumor development in patients and to work in the design of new treatments.
IBEC contributes to elucidate how the rigidity of the tumor extracellular matrix affects the aggressiveness of neuroblastoma, a cancerous tumor that affects mainly children. This opens the door to generate more accurate models to predict tumor development in patients and to work in the design of new treatments. Neuroblastoma is the most frequent malignant tumor in the first year of life. It is caused by a genetic mutation from immature nerve cells (neuroblasts) that the fetus produces as part of its development process.
Newsletter
[newsletter]